BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Bright Settles Dismissal Complaint While Whistleblower Case Continues

  The Trump White House removed Bright from his position at BARDA and reassigned him to a narrower role at the National Institutes of Health.

  August 10, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Pandemic Highlights Opportunities, Challenges for Exosomes and Related Cell Therapies

  New therapeutic modalities always face an uphill climb, but the urgency of COVID-19 may have opened the door for two related ones: cell therapies and exosomes.

  August 10, 2021

   · 

  7 min read

   · 

  Mark Zipkin
• 

  Business

  BioLife Solutions Strengthens Gene Therapy Capabilities with $24 Million Acquisition

  BioLife will obtain all of the outstanding shares of Sexton that it doesn’t already own for $24 million in consideration for 506,382 newly issued shares of BioLife common stock.

  August 10, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  mRNA Disruptor Goes Public in $1.5 Billion SPAC Deal

  Messenger RNA has become the life sciences hero of the decade. The lynchpin in the fight against COVID-19, companies are taking mRNA technology to new heights.

  August 10, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  COVID-19 Vaccines Expiring in Wealthy Nations as Developing World Struggles

  In India, only 8.3% of the population is fully vaccinated, while Sudan, Myanmar, and Ethiopia all have blank spaces beside their names in that category.

  August 10, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Santen, Sydnexis Unite to Vanquish Childhood Myopia

  Global biopharmaceutical firms Santen SA and Sydnexis have entered an exclusive licensing deal for a drug formulation that aims to treat progressive myopia.

  August 10, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Fecal Transplants Could Be New Tool in Fight Against Age-Related Decline

  Recent animal research reported in Nature Aging on Monday suggests fecal transplants may actually reverse the signs of brain aging.

  August 10, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  BioForest

  Pharma Firm Earns $20 Million to Support Presbyopia Treatment Efforts

  Visus Therapeutics has acquired an additional $20 million in funding to support its mission of developing innovative ophthalmic therapies for people worldwide.

  August 10, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Aldevron, Ginkgo Bioworks Tout “Breakthrough” in mRNA Manufacturing

  Months after landing a massive SPAC deal that carried Ginkgo Bioworks to the Nasdaq, the company is now touting a manufacturing breakthrough from partner Aldevron for mRNA vaccine components.

  August 10, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Fera Pharma Pounces on Abandoned Pfizer Pediatric Glaucoma Drug

  Pfizer has made a deal with the small Locust Valley, New York-based company to manufacture and market the drug.

  August 10, 2021

   · 

  2 min read

   · 

  Mark Terry